It's not that hard to google. There's a reason this sector is unregulated and has a lot of money thrown via grants. This is prolly the primary reason a pink sheets company even got the license to begin with, no one wants to do it. Paul should be able to negotiate with a university to conduct the trials + the university to get a grant from the NIH or FDA.
Market Data 
Markets 
AI
